CRISPR Therapeutics AG (CRSP) News

CRISPR Therapeutics AG (CRSP): $49.72

6.23 (+14.33%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add CRSP to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#282 of 337

in industry

Filter CRSP News Items

CRSP News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

CRSP News Highlights

  • 404 Page not found

    Error: Page not found

    The requested URL was not found on this server.

  • 404 Page not found

    Error: Page not found

    The requested URL was not found on this server.

  • 404 Page not found

    Error: Page not found

    The requested URL was not found on this server.

Latest CRSP News From Around the Web

Below are the latest news stories about CRISPR THERAPEUTICS AG that investors may wish to consider to help them evaluate CRSP as an investment opportunity.

3 Mid-Cap Stocks That Could Take Off in 2025

Mid-cap stocks represent companies valued at between $2 billion and $10 billion. If they give investors a reason to be bullish on their growth prospects or show that they're on the right path, these types of investments can double in value and be 10-baggers in the long run. Iovance Biotherapeutics has a market cap of $2.3 billion.

Yahoo | January 9, 2025

CRISPR Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

ZUG, Switzerland and BOSTON, Jan. 08, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 2:15 p.m. PT in San Francisco. A live webcast of the fireside chat will be available on the "Events & Presentations" page in the Investor

Yahoo | January 8, 2025

CRISPR Therapeutics AG (CRSP) Registers a Bigger Fall Than the Market: Important Facts to Note

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $41.92, moving -1.2% from the previous trading session.

Yahoo | January 7, 2025

CRISPR Therapeutics Proposes New Appointment to the Board of Directors

ZUG, Switzerland and BOSTON, Jan. 07, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced it proposes to elect Briggs Morrison, M.D., to its Board of Directors at the Company’s annual general meeting to be held this year. “We are excited to welcome Briggs to our Board of Directors,” said Samarth Kulkarni, Ph.D., Chief Executive Officer and Chairman of the Board of CR

Yahoo | January 7, 2025

Vertex, startup Orna to partner on gene editing research

The three-year partnership is another example of Vertex’s interest in improving on Casgevy, its CRISPR medicine for sickle cell and beta thalassemia.

Yahoo | January 7, 2025

CRISPR Therapeutics AG (CRSP) Increases Despite Market Slip: Here's What You Need to Know

In the closing of the recent trading day, CRISPR Therapeutics AG (CRSP) stood at $39.36, denoting a +1.84% change from the preceding trading day.

Yahoo | December 31, 2024

Why Is CRISPR Therapeutics AG (CRSP) Among the Top CRISPR Stocks to Invest In?

We recently compiled a list of the Top 11 CRISPR Stocks to Invest In. In this article, we are going to take a look at where CRISPR Therapeutics AG (NASDAQ:CRSP) stands against the other CRISPR stocks. The pharmaceutical industry is buzzing with innovation, driven by the need for new treatments, tackling unmet medical challenges, and leveraging […]

Yahoo | December 30, 2024

CRISPR Therapeutics AG (CRSP): Is This Gene Therapy Stock a Good Buy Right Now?

We recently compiled a list of the 10 Best Gene Therapy Stocks to Buy Right Now. In this article, we are going to take a look at where CRISPR Therapeutics AG (NASDAQ:CRSP) stands against the other gene therapy stocks. Gene therapy is referred to as a medical technique that involves modifying or manipulating genes to treat or […]

Yahoo | December 29, 2024

CRISPR Therapeutics AG (CRSP) Advances While Market Declines: Some Information for Investors

The latest trading day saw CRISPR Therapeutics AG (CRSP) settling at $41.07, representing a +0.32% change from its previous close.

Yahoo | December 26, 2024

Institutional investors may adopt severe steps after CRISPR Therapeutics AG's (NASDAQ:CRSP) latest 8.3% drop adds to a year losses

Key Insights Institutions' substantial holdings in CRISPR Therapeutics implies that they have significant influence...

Yahoo | December 25, 2024


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!